Dianthus Therapeutics, Inc. /DE/ Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 5,785.89%-445.07%-1,536.09%-1,355.24%
EBIT Margin 5,685.89%-462.91%-1,704.67%-1,633.74%
EBITDA Margin 5,785.89%-446.27%-1,533.86%-1,361.83%
Operating Margin 5,685.89%-462.91%-1,704.67%-1,633.74%
Net Margin 5,972.39%-445.07%-1,536.09%-1,355.24%
FCF Margin 4,235.58%-455.18%-1,308.24%-1,255.57%
Efficiency
Assets Average 105.89M159.41M131.26M276.71M
Equity Average 51.77M143.42M62.25M260.67M
Invested Capital -42.12M145.65M141.19M-44.37M168.87M352.48M
Asset Utilization Ratio 0.020.02
Leverage & Solvency
Interest Coverage Ratio -56.86
Equity Ratio -0.770.930.87-0.530.940.94
Times Interest Earned -56.86
Valuation
Enterprise Value -4.51M-51.57M46.39M445.35M-51.57M-19.61M369.97M
Market Capitalization 188.96M591.08M23.92M154.10M645.21M
Return Ratios
Return on Sales 57.86%-4.45%-15.36%-13.55%
Return on Capital Employed -0.63%-0.57%-0.40%-0.39%
Return on Assets -0.54%-0.48%-0.33%-0.31%
Return on Equity -1.11%-0.54%-0.70%-0.32%